Cite
HARVARD Citation
Papageorgiou, S. et al. (2018). Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group. Leukemia research. pp. 55-59. [Online].